RESUMO
This study examines public trust in government and public belief in its truthfulness in respect of the measures it is taking to combat COVID-19. Analysing global data from the International Coronavirus Survey of 178 countries between 20 March and 8 April 2020, we establish that integrated government response policies, underpinned by containment health measures and economic reliefs, are crucial to winning public trust and support. We find that a one standard deviation increase in composite government response measures leads to a 0.353% increase in public trust in government and a 0.414% increase in public belief in its truthfulness. The impacts vary according to legal systems, whose political ethos determines the quality of welfare services and their ability to respond to citizens' needs during a public health emergency. Further, public trust in government measures differs in relation to how a country's system of governance and institutional culture respond to meet public expectations, with citizens' attitudes influenced by the fairness, effectiveness and accountability of government agencies. Most importantly, our evidence consistently demonstrates that the provision of impartial, transparent and truthful government communications is vital for maintaining public trust. Moreover, experience gained from previous pandemics, reinforcing a nation's preparedness and responsiveness to future public health crises, is crucial to ensuring citizens' confidence in government competence. Overall, our original investigation reveals a contention between the exigencies of government policies and public expectations in a global health emergency, and has profound implications for public management and business and economic regeneration in the aftermath of the pandemic, laying the foundations for future research.
RESUMO
Since the first recorded case of SARS-CoV-2 in Bangladesh on 8th March 2020, COVID-19 has spread widely through different regions of the country, resulting in a necessity to re-evaluate the delivery of cardiovascular services, particularly procedures pertaining to interventional cardiology in resource-limited settings. Given its robust capacity for human-to-human transmission and potential of being a nosocomial source of infection, the disease has specific implications on healthcare systems and health care professionals faced with performing essential cardiac procedures in patients with a suspected or confirmed diagnosis of COVID-19. The limited resources in terms of cardiac catheterization laboratories that can be designated to treat only COVID positive patients are further compounded by the additional challenges of unavailability of widespread rapid testing on-site at tertiary cardiac hospitals in Bangladesh. This document prepared for our nation by the Bangladesh Society of Cardiovascular Interventions (BSCI) is intended to serve as a clinical practice guideline for cardiovascular health care professionals, with a focus on modifying standard practice of care during the COVID-19 pandemic, in order to ensure continuation of adequate and timely treatment of cardiovascular emergencies avoiding hospital-based transmission of SARS-COV-2 among healthcare professionals and the patients. This is an evolving document based on currently available global data and is tailored to healthcare systems in Bangladesh with particular focus on, but not limited to, invasive cardiology facilities (cardiac catheterization, electrophysiology & pacing labs). This guideline is limited to the provision of cardiovascular care, and it is expected that specific targeted pharmaco-therapeutics against SARS-CoV-2 be prescribed as stipulated by the National Guidelines on Clinical Management of Corona virus Disease 2019 (COVID-19) published by the Director General of Health Services, Ministry of Health and Family Welfare of Bangladesh.